PRESS RELEASE published on 06/10/2026 at 00:00, 1 month 4 days ago Terms of availability of the preparatory documents for the GM ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
BRIEF published on 06/09/2026 at 19:05, 1 month 4 days ago ABL Diagnostics prépare son Assemblée Générale du 30 juin 2026 Assemblée Générale Investisseurs Documents Préparatoires Biologie Moléculaire ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 1 month 4 days ago ABL Diagnostics Announces General Meeting on June 30, 2026 Shareholders Financial Statements Paris General Meeting ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 1 month 4 days ago ABL Diagnostics is preparing for its General Assembly on June 30, 2026 Investors General Assembly Preparatory Documents Molecular Biology ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 1 month 4 days ago ABL Diagnostics annonce la tenue de son assemblée générale le 30 juin 2026. Actionnaires Paris Assemblée Générale États Financiers Diagnostics ABL
PRESS RELEASE published on 06/09/2026 at 19:00, 1 month 4 days ago Modalités de mise à disposition des documents préparatoires à l'AG ABL Diagnostics convoque ses actionnaires en Assemblée Générale le 30 juin 2026 pour statuer sur les comptes annuels. Des tests de biologie moléculaire et solutions globales sont proposés Assemblée Générale Comptes Annuels ABL Diagnostics Solutions Globales Tests De Biologie Moléculaire
PRESS RELEASE published on 06/09/2026 at 19:00, 1 month 4 days ago Terms of availability of the preparatory documents for the GM ABL Diagnostics invites shareholders to the Ordinary and Extraordinary General Meeting on June 30, 2026, to discuss annual financial statements and more. Consult documents on company's website Shareholders Financial Statements General Meeting Molecular Biology ABL Diagnostics
BRIEF published on 05/08/2026 at 00:06, 2 months 6 days ago ABL Diagnostics Publishes its 2025 Annual Financial Report Euronext Paris General Assembly Molecular Biology ABL Diagnostics Financial Report 2025
BRIEF published on 05/08/2026 at 00:06, 2 months 6 days ago ABL Diagnostics Publie son Rapport Financier Annuel 2025 Euronext Paris Assemblée Générale Biologie Moléculaire ABL Diagnostics Rapport Financier 2025
PRESS RELEASE published on 05/08/2026 at 00:01, 2 months 6 days ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel ABL Diagnostics annonce la mise \u00e0 disposition de son rapport financier annuel 2025, consultable sur son site. Assembl\u00e9e g\u00e9n\u00e9rale pr\u00e9vue le 30 juin 2026 \u00e0 Paris. Pr\u00e9sentation de ses produits et services Rapport Financier Assembl\u00e9e G\u00e9n\u00e9rale ABL Diagnostics Produits Et Services Biologie Mol\u00e9culaire
Published on 07/14/2026 at 01:45, 2 hours 40 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 4 hours 24 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 5 hours 15 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 6 hours 50 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 8 hours 25 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 5 hours 55 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 7 hours 4 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 7 hours 7 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 7 hours 37 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 8 hours 2 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 10 hours 25 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 10 hours 25 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 10 hours 25 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026